Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price boosted by Barclays from $58.00 to $60.00 in a research ...
On Monday, Tandem Diabetes Care Inc (TNDM) stock saw a modest uptick, ending the day at $31.37 which represents a slight increase of $0.77 or 2.52% from the prior close of $30.6. The stock opened at ...
On Friday, Tandem Diabetes Care Inc (TNDM) stock saw a decline, ending the day at $30.6 which represents a decrease of $-2.72 or -8.16% from the prior close of $33.32. The stock opened at $33.71 and ...
Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) were down 9.6% on Friday after Canaccord Genuity Group lowered their price target on the stock from $57.00 to $56.00. Canaccord ...
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of 16.28% and 9.24%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock ...
While the top- and bottom-line numbers for Tandem Diabetes Care (TNDM) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key ...
Fintel on MSN6d
Bernstein Initiates Coverage of Tandem Diabetes Care (TNDM) with Outperform RecommendationFintel reports that on November 6, 2024, Bernstein initiated coverage of Tandem Diabetes Care (NasdaqGM:TNDM) with a ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Waters (WAT – Research Report), Pharvaris ...
ATRS -42% on providing XYOSTED regulatory update.TNDM -32% on announcing proposed public offering of common stock.AAOI -20% on announcing Q3 preliminary results.RNN -17% on... Tandem Diabetes Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback